Pharmacy Liaison Probe Must Be More ‘Rigorous’ to Get FTC Vote

Feb. 23, 2022, 10:00 AM UTC

FTC Commissioner Noah J. Phillips said he supports probing the entities that manage prescription drug coverage for insurers, but that the proposed study he voted against launching wasn’t “rigorous” enough to attract his support.

Phillips, one of two Republicans on the Federal Trade Commission, told Bloomberg Law that the proposal to look into pharmacy benefit managers didn’t clarify what exactly the agency would review and whether it would account for consumer drug costs.

He said he’s open to working with his fellow commissioners on developing a new study into a part of the health-care industry that has traditionally remained without ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.